PL3071192T3 - Związek kurkufenol do zastosowania w leczeniu nowotworu - Google Patents
Związek kurkufenol do zastosowania w leczeniu nowotworuInfo
- Publication number
- PL3071192T3 PL3071192T3 PL14815145T PL14815145T PL3071192T3 PL 3071192 T3 PL3071192 T3 PL 3071192T3 PL 14815145 T PL14815145 T PL 14815145T PL 14815145 T PL14815145 T PL 14815145T PL 3071192 T3 PL3071192 T3 PL 3071192T3
- Authority
- PL
- Poland
- Prior art keywords
- treating cancer
- curcuphenol compound
- curcuphenol
- compound
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361906817P | 2013-11-20 | 2013-11-20 | |
| EP14815145.9A EP3071192B1 (en) | 2013-11-20 | 2014-11-20 | Curcuphenol compound for use in treating cancer |
| PCT/US2014/066543 WO2015077411A1 (en) | 2013-11-20 | 2014-11-20 | Curcuphenol compounds for increasing mhc-i expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3071192T3 true PL3071192T3 (pl) | 2020-06-29 |
Family
ID=52117996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14815145T PL3071192T3 (pl) | 2013-11-20 | 2014-11-20 | Związek kurkufenol do zastosowania w leczeniu nowotworu |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20150147314A1 (pl) |
| EP (2) | EP3071192B1 (pl) |
| JP (4) | JP6560215B2 (pl) |
| CN (1) | CN106456572A (pl) |
| CA (1) | CA2930156C (pl) |
| DK (1) | DK3071192T3 (pl) |
| ES (1) | ES2775577T3 (pl) |
| HU (1) | HUE049301T2 (pl) |
| PL (1) | PL3071192T3 (pl) |
| WO (1) | WO2015077411A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3071192T3 (da) | 2013-11-20 | 2020-03-16 | Cava Healthcare Inc | Curcuphenolforbindelse til anvendelse i behandling af cancer |
| WO2017015615A1 (en) * | 2015-07-22 | 2017-01-26 | Teva Pharmaceuticals International Gmbh | Pridopidine base formulations and their use |
| US12297200B2 (en) * | 2018-12-17 | 2025-05-13 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines synthesis |
| KR20220004952A (ko) * | 2019-01-31 | 2022-01-12 | 카바 헬스케어 아이엔씨. | Mhc-i 발현 증가 및 히스톤 디아세틸라제 활성 조절을 위한 화합물 |
| WO2022033465A1 (zh) * | 2020-08-10 | 2022-02-17 | 萧乃文 | 具有协同抗癌功效的氯硝柳胺和双硫仑医药组合物及其用途 |
| WO2022125339A2 (en) * | 2020-12-07 | 2022-06-16 | The Trustees Of Indiana University | Methods to sensitize cancer cells to immune attack using atractylenolide i |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6261939A (ja) * | 1985-09-10 | 1987-03-18 | Yamanouchi Pharmaceut Co Ltd | クルクフエノ−ル誘導体及びこれを含有する医薬 |
| KR100439425B1 (ko) * | 2001-03-22 | 2004-07-05 | (주)바이오케어 | 잔토리졸을 포함하는 조성물 및 그 용도 |
| CN1842326A (zh) * | 2003-06-24 | 2006-10-04 | 生物关怀有限公司 | 癌症化疗药物所引起的毒性的抑制剂以及含有该抑制剂的癌症化疗药物组合物 |
| WO2008144880A1 (en) * | 2007-05-31 | 2008-12-04 | F.P.L. Pharma Inc. | Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| DK3071192T3 (da) | 2013-11-20 | 2020-03-16 | Cava Healthcare Inc | Curcuphenolforbindelse til anvendelse i behandling af cancer |
-
2014
- 2014-11-20 DK DK14815145.9T patent/DK3071192T3/da active
- 2014-11-20 PL PL14815145T patent/PL3071192T3/pl unknown
- 2014-11-20 HU HUE14815145A patent/HUE049301T2/hu unknown
- 2014-11-20 CN CN201480072728.3A patent/CN106456572A/zh active Pending
- 2014-11-20 EP EP14815145.9A patent/EP3071192B1/en active Active
- 2014-11-20 EP EP19216024.0A patent/EP3639815A1/en not_active Withdrawn
- 2014-11-20 CA CA2930156A patent/CA2930156C/en active Active
- 2014-11-20 US US14/548,726 patent/US20150147314A1/en not_active Abandoned
- 2014-11-20 JP JP2016533609A patent/JP6560215B2/ja active Active
- 2014-11-20 WO PCT/US2014/066543 patent/WO2015077411A1/en not_active Ceased
- 2014-11-20 ES ES14815145T patent/ES2775577T3/es active Active
-
2017
- 2017-01-25 US US15/415,291 patent/US10751296B2/en active Active
-
2019
- 2019-07-18 JP JP2019132434A patent/JP2019196380A/ja not_active Withdrawn
-
2020
- 2020-08-20 US US16/998,072 patent/US11197832B2/en not_active Expired - Fee Related
-
2021
- 2021-04-06 JP JP2021064761A patent/JP7071570B2/ja not_active Expired - Fee Related
- 2021-11-08 US US17/521,674 patent/US12011421B2/en active Active
-
2022
- 2022-05-09 JP JP2022076869A patent/JP2022093724A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20150147314A1 (en) | 2015-05-28 |
| JP7071570B2 (ja) | 2022-05-19 |
| CN106456572A (zh) | 2017-02-22 |
| US11197832B2 (en) | 2021-12-14 |
| WO2015077411A1 (en) | 2015-05-28 |
| DK3071192T3 (da) | 2020-03-16 |
| JP2016539129A (ja) | 2016-12-15 |
| EP3071192A1 (en) | 2016-09-28 |
| US20170319508A1 (en) | 2017-11-09 |
| JP2021100982A (ja) | 2021-07-08 |
| EP3071192B1 (en) | 2019-12-18 |
| US10751296B2 (en) | 2020-08-25 |
| US12011421B2 (en) | 2024-06-18 |
| US20220062195A1 (en) | 2022-03-03 |
| JP2019196380A (ja) | 2019-11-14 |
| HUE049301T2 (hu) | 2020-09-28 |
| EP3639815A1 (en) | 2020-04-22 |
| JP2022093724A (ja) | 2022-06-23 |
| US20200375917A1 (en) | 2020-12-03 |
| CA2930156A1 (en) | 2015-05-28 |
| ES2775577T3 (es) | 2020-07-27 |
| CA2930156C (en) | 2023-11-07 |
| JP6560215B2 (ja) | 2019-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292193A (en) | Anti-b7–h1 antibodies for the treatment of tumors | |
| IL245731A0 (en) | Combined treatment for cancer | |
| IL245281A0 (en) | Methods and preparations for the treatment of cancer | |
| GB2516814B (en) | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer | |
| PL3967315T3 (pl) | Akkermansia muciniphila do leczenia nowotworu złośliwego | |
| SG11201603050TA (en) | Methods for treating cancers | |
| ZA201603332B (en) | Gla monotherapy for use in cancer treatment | |
| GB201322725D0 (en) | Cancer therapy | |
| IL244353A0 (en) | Compounds and use for cancer treatment | |
| SG10201913730RA (en) | Cancer therapy | |
| SG11201507847UA (en) | Cancer therapy | |
| ZA201505937B (en) | Caix stratification based cancer treatment | |
| PL2968226T3 (pl) | Kompozycje oksprenololu do leczenia raka | |
| IL245037B (en) | Treatment for pancreatic cancer | |
| GB201304872D0 (en) | Treatment | |
| LT3016682T (lt) | Vėžio gydymo būdai | |
| PL3071192T3 (pl) | Związek kurkufenol do zastosowania w leczeniu nowotworu | |
| PT2915800T (pt) | Compostos derivados de ingenol que podem ser utilizados para tratamento do cancro | |
| EP2961412A4 (en) | CANCER THERAPY | |
| GB201307310D0 (en) | Treatment | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| GB201300546D0 (en) | Cancer Treatment | |
| GB201321531D0 (en) | Treatment for cancers | |
| GB201322764D0 (en) | Treating places | |
| GB201317213D0 (en) | Cancer Therapy |